EpiCeram
EpiCeram Skin Barrier Emulsion is a steroid-free, fragrance-free, ceramide-dominant topical formulation. It is indicated to treat dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatoses, including atopic dermatitis. EpiCeram Skin Barrier Emulsion helps to relieve dry, waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process.

Visit the EpiCeram website at www.epiceram.ca

NYDA
NYDA is indicated for the treatment and eradication of head lice. In September 2011, Health Canada issued a notification of compliance (approval) for NYDA. The efficacy of NYDA is exclusively based on a physical mode of action. This is important given the resistance present for current pesticide therapies approved in Canada. The “point of attack” of the physical mode of action of NYDA is the insect’s respiratory system. NYDA works by suffocating the lice, nymphs and the embryos in the eggs. This mode of action prevents development of resistance.

The key to getting rid of head lice lies in killing the nits (eggs), NYDA kills all three stage from eggs to adult lice.

Suprax
Indicated for the treatment of pharyngitis, tonsillitis, otitis media, sinusitis and acute bronchitis caused by susceptible strains of S. pyogenes, S. pneumoniae, H. influenzae and M. catarrhalis

Kool-Effects Patch (OTC)
Innovative biogel patch that reduces the symptoms of fever or headaches. Launch planned for 2012

VapoLyptus Patch (OTC)
Innovative product promoting the clearing of air passages in children with cold symptoms or allergies during bedtime. Launch planned for 2012